Evidence map›Paper›PMID 42504986›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Polychip-A High-Throughput Droplet Microfluidics Platform for Interrogating Microbial Interactions.

Jeong Jae Han, Adrian Ryan Guzman, Aifen Zhou, Han Zhang, Rohit Gupte, Haemin Jung, Kaylee Delgado, Sini Skariah, Ali Sultan, Arul Jayaraman and 2 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jeong Jae HanDepartment of Multidisciplinary Engineering, Texas A&M University, College Station, Texas, USA.ORCID https://orcid.org/0009-0004-3972-3166
Adrian Ryan GuzmanDepartment of Electrical and Computer Engineering, Texas A&M University, College Station, USA.
Aifen ZhouDepartment of Chemical Engineering, Texas A&M University, College Station, USA.
Han ZhangDepartment of Electrical and Computer Engineering, Texas A&M University, College Station, USA.
Rohit GupteDepartment of Biomedical Engineering, Texas A&M University, College Station, USA.
Haemin JungDepartment of Electrical and Computer Engineering, Texas A&M University, College Station, USA.ORCID https://orcid.org/0000-0001-5441-1663
Kaylee DelgadoDepartment of Microbial Pathogenesis and Immunology, Texas A&M University, College Station, USA.
Sini SkariahDepartment of Microbiology and Immunology, Weill Cornell Medicine - Qatar, Cornell University, Education City, Doha, Qatar.
Ali SultanDepartment of Microbiology and Immunology, Weill Cornell Medicine - Qatar, Cornell University, Education City, Doha, Qatar.
Arul JayaramanDepartment of Chemical Engineering, Texas A&M University, College Station, USA.
Paul de FigueiredoChristopher S. Bond Life Sciences Center, University of Missouri, Columbia, USA.
Arum HanDepartment of Multidisciplinary Engineering, Texas A&M University, College Station, Texas, USA.ORCID https://orcid.org/0000-0002-9223-8301

Funding

Development of a High-Throughput Microfluidics-Enabled Functional Assay for Rapidly Identifying Neutralizing AntibodiesR01AI141607 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI DE FIGUEIREDO, PAUL, HAN, ARUM · 2019 to 2023
$3.4M
GUARD: A global unbiased antimicrobial discovery platformR01AI168685 · NIAID · TEXAS ENGINEERING EXPERIMENT STATION · PI ARUL JAYARAMAN · 2023 to 2026
$3.0M
Accelerating discovery of neutralizing paratopes with Functional Antibody Screening TechnologyR21AI139738 · NIAID · TEXAS A&M UNIVERSITY · PI HAN, ARUM · 2020 to 2021
$415k
Defense Advanced Research Projects Agency (DARPA) W911NF1920013,HR00112320006National Institute of Allergy and Infectious Diseases 1R01AI168685-01A1National Institute of Allergy and Infectious Diseases R01AI141607-01A1National Institute of Allergy and Infectious Diseases R21AI139738-01A1NIAID NIH HHS R01 AI141607NIAID NIH HHS R01 AI168685NIAID NIH HHS R21 AI139738NIH HHSQatar National Research Foundation NPRP9-001-2-001Texas A&M University Advancing Discovery to Market M2404535
6 · The paper itself

Abstract

Microbial interactions are fundamental to ecology, health, and disease, yet high-throughput tools to study these complex relationships remain scarce. We introduce Polychip, a fully integrated, high-throughput droplet microfluidics platform that revolutionizes microbial interaction screening. By seamlessly combining six microfluidic operations onto a single chip, Polychip achieves 99.7% efficiency and accelerates screening by 11-14 times compared to traditional high-throughput liquid handling robotic methods, with minimal human input. Using the Polychip, we screened 2.24 × 10

Indexed as

antimicrobial discoverydroplet microfluidicsenvironmental microorganismshigh‐throughput screeningpolymicrobial interactions

Identifiers

PMID42504986
PMCPMC13403381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.